| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |